文章：

美国健康政策与结直肠癌筛查

Health Policy and Screening for Colorectal Cancer in the United States

原文发布日期：16 June 2025

DOI: 10.3390/cancers17122003

类型: Article

开放获取: 是

英文摘要：

The landscape for the screening of colorectal cancer (CRC) has witnessed multiple triumphs over the past decades from policy-level interventions. In the United States (US), the most prominent intervention of this nature is the Patient Protection and Affordable Care Act (ACA), enacted more than a decade ago. Since its enactment, the ACA has seen multiple legal challenges, and its impact on CRC screening has been relatively well studied. However, a consolidated, concise analysis of the data on this subject is lacking. Herein, we evaluate the impact of the ACA on CRC screening through the lens of a policy analysis, highlighting its strengths and shortcomings, and suggest policy-level interventions to address these shortcomings and improve CRC screening adoption.

摘要翻译： 

在过去的几十年中，结直肠癌筛查领域因政策层面的干预取得了多项显著成就。在美国，最具代表性的此类干预措施是十多年前颁布的《患者保护与平价医疗法案》。自该法案实施以来，其经历了多次法律挑战，且其对结直肠癌筛查的影响已得到较为充分的研究。然而，目前尚缺乏对该主题数据的系统化、简明分析。本文通过政策分析的视角，评估了《患者保护与平价医疗法案》对结直肠癌筛查的影响，重点分析了其优势与不足，并提出了政策层面的干预建议以弥补这些不足，促进结直肠癌筛查的普及。

原文链接：

Health Policy and Screening for Colorectal Cancer in the United States